In cooperation with the RISE program and our Clinician Scientists, a scientific talk with the title “Adjuvant therapy and treatment of advanced disease in adrenocortical carcioma (ACC): New perspectives.” by speaker Otilia Kimpel takes place on 19.08.2021. Further information see below.
Read MoreAuthor: Eva Spickenheuer
New funding period granted!
The DFG has approved a continuation of the CRC/TRR 205, therefore we enter the second funding period. All members are happy about the result and about the opportunity to continue working on this exciting topic.
Read MoreDGE-Awards for CRC members
During the DGE meeting, prizes were awarded to CRC members. The Bruno Allolio Prize was awarded to Dr. Nicole Bechman for her work: Hypoxia inducible factor 2 α (HIF2α) promotes a pro-metastatic phenotype in pheochromocytomas and paragangliomas. The Anke Mey Prize was awarded to Laura-Sophie Landwehr and Jochen Schreiner for their work: A novel patient-derived […]
Read MoreEnd(o)ZEIT seminar talk of Prof. Graeme Eisenhofer
The End(o)ZEIT seminar talk of Prof. Graeme Eisenhofer entitled „Phaeochromocytoma and paraganglioma: catecholamine secretory pathways and metabologenomics” takes place on Tuesday April 27th at 2:15p.m. online via ZOOM.
Read MoreIFCAH First (DIGITAL) Symposium – 10 years CAH Research Support
When: Monday 14th June 2021, from 4.00 pm to 7.00 pm CET IFCAH is pleased to welcome all patients, patient’s families, researchers and clinicians to share their very last findings on CAH, obtained thanks to 10 years of IFCAH support. International CAH experts will present their last results issued from their research work and respond […]
Read MoreGeorgiana Constantinescu awarded as Harvard Outstanding Teaching Assistant 2020
Georgiana Constantinescu, member of the CRC/TRR 205 and part of the Clinician Scientists program was awarded as a 2020 Outstanding Teaching Assistant by the Harvard Medical School. Georgiana joined the Clinician Scientists program in 2018 and was offered to take the seminar Principles and Practice of Clinical Research by the Harvard School of Public Health. […]
Read MoreNew PI Holger Henneicke: “Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice”
New PI Holger Henneicke recently published the paper: “Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice”. Starting as an Clinician Scientist, we are proud to win Holger Henneicke as a new PI for the CRC/TRR 205.
Read MoreTransregional Collaborative Research Center 127 “Biology of xenogeneic cell, tissue and organ transplantation – from bench to bedside” enters the third funding phase
For many chronic diseases, the replacement of irreversibly damaged organs or tissue is the last therapeutic option. The demand for cells, tissues and organs for transplantation is currently far from being met by the available human donors. Therefore, the use of animal tissues and organs for xenotransplantation has been discussed for more than three decades. […]
Read More“Corticotroph Tumor Progression after Bilateral Adrenalectomy (Nelson’s syndrome): Systematic Review and Expert Consensus Recommendations”
An interdisciplinary workshop of international pituitary experts coordinated by Martin Reincke, reached a consensus on the important issue of “Corticotroph Tumor Progression after Bilateral Adrenalectomy (Nelson’s syndrome): Systematic Review and Expert Consensus Recommendations”, which has just been accepted for publication in the European Journal of Endocrinology (http://dx.doi.org/10.1530/EJE-20-1088)
Read MoreMasks not dangerous for children – an article supported by CRC members
The German article “Nein, dieser Kinderarzt belegt keine Gefahren für Kinder durch Masken” published on Friday, 08.01.2021 on AFP Faktencheck was supported with expert advice by Prof. Dr. Angela Hübner and Prof. Dr. Dr. Matthias Kroiß. The article can be found here.
Read More